NEWS AND EVENTS

Dr. Jon Daniels to present 'Safety Evaluation of Anticancer Drugs' to Support Clinical Trials and Marketing Authorization

Dr. Jon Daniels has been invited to give a presentation at the upcoming Discovery to Development Symposium on Oncology and Biomarkers which will take place in May 2010. The title of Dr. Daniels’ presentation will be Safety Evaluation of Anticancer Drugs to Support Clinical Trials and Marketing Authorization. More details regarding the talk and symposium will be posted shortly. In the last seven years, the Intrinsik team has been responsible for driving over 70 nonclinical development programs for their clients’ new human therapeutics (NCEs/NMEs), of which approximately 25% have been in the anticancer area.